leadf
logo-loader
viewAstraZeneca

AstraZeneca to issue debt at 0.7% interest rate

The issue is part of a three-tranche global bond offering totalling $3bn that is expected to close on 6 August.

AstraZeneca -

AstraZeneca PLC (LON:AZN), the FTSE100 pharma group, is to issue US$1.2bn of bonds with a rate of interest of just 0.7%.

The issue is part of a three-tranche global bond offering totalling $3bn that is expected to close on 6 August.

The 0.7% bonds mature in April 2026 and are being issued alongside a tranche of US$1.3bn notes that mature in 2030 with a coupon of 1.375% and US$0.5bn of 2.125% long term debt maturing in 2050.

AstraZeneca became the UK’s largest listed company earlier this year on the back of its strong pipeline of drugs in development.

Quick facts: AstraZeneca

Price: 8580 GBX

LSE:AZN
Market: LSE
Market Cap: £112.59 billion
Follow

Add related topics to MyProactive

Create your account: sign up and get ahead on news and events

NO INVESTMENT ADVICE

The Company is a publisher. You understand and agree that no content published on the Site constitutes a recommendation that any particular security, portfolio of securities, transaction, or investment strategy is...

FOR OUR FULL DISCLAIMER CLICK HERE

Adastra Labs state of the art facility just one of the advantages the...

Adastra Labs (CSE: XTRX) CEO Andy Hale joined Steve Darling from Proactive to share details about the cannabis processing and analytical testing services company. Hale discusses their state-of-the-art facility in Langley, British Columbia and the new equipment they are installing. Hale also...

8 hours, 30 minutes ago

2 min read